Opioid Free Management After Ureteroscopy
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Nephrology, Nephrology |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/15/2019 |
| Start Date: | April 2019 |
| End Date: | May 2020 |
| Contact: | Taylor Peak, MD |
| Email: | tpeak@wakehealth.edu |
| Phone: | 336-716-5710 |
A Prospective Double Blind Randomized Control Trial Comparing Opioid to Non-Opioid Protocol in Managing Postoperative Pain After Ureteroscopy With Stent Placement
The purpose of this research study is to compare how well two medications work to control
post-operative pain.
post-operative pain.
This will be a randomized double blinded control trial with subjects randomized to either
opioid group (Norco 5-325 milligram) or a non-opioid group (Ibuprofen 400 milligram).
Subjects with a renal stones who are consented for a ureteroscopy will be eligible for the
study. Subjects eligible for the study will have a discussion with the study team member
about treatment options. Subjects can either elect not to be in the study and actively choose
which treatment is preferable, or the subject can choose to enter the study and be randomized
to one of these treatment arms. The ureteroscopy will be performed using standard of care
instruments and techniques. No changes to operative technique will be performed for subjects
in the study vs regular patients undergoing the same procedure. Post operatively;
investigators plan to discharge all subjects home from the recovery unit. All subjects will
be seen one week after surgery for follow up, questioner filling and stent removal.
opioid group (Norco 5-325 milligram) or a non-opioid group (Ibuprofen 400 milligram).
Subjects with a renal stones who are consented for a ureteroscopy will be eligible for the
study. Subjects eligible for the study will have a discussion with the study team member
about treatment options. Subjects can either elect not to be in the study and actively choose
which treatment is preferable, or the subject can choose to enter the study and be randomized
to one of these treatment arms. The ureteroscopy will be performed using standard of care
instruments and techniques. No changes to operative technique will be performed for subjects
in the study vs regular patients undergoing the same procedure. Post operatively;
investigators plan to discharge all subjects home from the recovery unit. All subjects will
be seen one week after surgery for follow up, questioner filling and stent removal.
Inclusion Criteria:
- Ureteroscopy performed for renal stones
- Age over 18 years
- Two kidneys
Exclusion Criteria:
- Solitary Kidney
- Poor kidney function (GFR<30)
- Allergy to either Ibuprofen or Norco
- Pelvic Kidney
We found this trial at
1
site
1 Medical Center Blvd
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2011
Principal Investigator: Jorge Gutierrez-Aceves, MD
Wake Forest University Health Sciences Welcome to Wake Forest Baptist Medical Center, a fully integrated...
Click here to add this to my saved trials
